Africa to Produce 60% of Own Medicine by 2040

African leaders just made a promise that could transform healthcare for more than a billion people. At the African Union Summit in Ethiopia, heads of state signed a declaration committing the continent to produce 60% of its own medicines, vaccines, and medical equipment by 2040.

The decision represents a massive shift in how Africa approaches health security. Currently, the continent imports most of its pharmaceuticals and medical supplies, making it vulnerable during global health crises like the COVID-19 pandemic.

The February 14 declaration establishes concrete steps to reach this ambitious goal. African nations will launch the African Pooled Procurement Mechanism, a "Buy African" initiative that guarantees local manufacturers will have customers for their products.

The mechanism solves a critical problem. African pharmaceutical companies often struggle because they can't predict demand or secure long-term buyers. By pooling orders from multiple countries, the new system creates stable, predictable markets that make manufacturing viable.

Leaders also committed to creating a special capital fund to help manufacturers get started or expand. The initiative includes technology transfer programs and skills development through Africa CDC's Regional Capacity Networks, ensuring the continent builds lasting expertise.

Kenya will host an Extraordinary Summit on African Health Products Manufacturing in mid-2026 to accelerate implementation. President William Samoei Ruto, serving as the AU Champion on Local Manufacturing, will chair the gathering focused on turning commitments into concrete action.

The declaration builds on previous African Union decisions and recognizes local manufacturing as essential to health sovereignty. When Africa can produce its own medical supplies, countries won't face shortages during global emergencies or pay inflated prices from distant suppliers.

The Ripple Effect: This initiative extends far beyond healthcare access. Local pharmaceutical manufacturing will create thousands of skilled jobs across the continent, from research scientists to factory workers. African nations will retain more healthcare dollars within their economies instead of sending them overseas. Countries will gain bargaining power in global health negotiations when they're not entirely dependent on imports. Most importantly, during the next pandemic or health crisis, African communities won't be last in line waiting for supplies to arrive from other continents.

Africa CDC is leading the coordination effort, bringing together 55 member states with different capabilities and needs. The harmonized approach means smaller nations can benefit from regional manufacturing hubs while building their own capacity over time.

By 2040, a child in Lagos or Nairobi could receive a life-saving vaccine manufactured just miles away, not shipped from another hemisphere.